← All trials
NCT05299593
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 4, 2020
- Primary completion
- Jun 30, 2022
- Completion date
- Jun 30, 2022
- First posted
- Mar 29, 2022
- Last posted
- Mar 29, 2022
- Enrollment
- 43
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fondazione G.B. Bietti, IRCCSLead sponsor
- University of MilanOverall official - principal investigator
- Fondazione G.B. Bietti, IRCCSOverall official - principal investigator
- University of MilanOfficial
- Fondazione G.B. Bietti, IRCCSOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.